Understanding how certain immune cells contribute to lupus
IRF7-mediated development of autoreactive B cells and SLE
This study is looking at how a specific gene affects certain immune cells in people with lupus, with the goal of finding better treatments that help manage the disease without making patients feel worse.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11098748 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind the development of autoreactive B cells in systemic lupus erythematosus (SLE), an autoimmune disease. The team aims to identify how the IRF7 gene influences these immune cells and their role in producing autoantibodies that attack the body. By studying these processes, the researchers hope to develop targeted therapies that are more effective and have fewer side effects than current treatments, which often suppress the entire immune system. This work could lead to better management of SLE and improved quality of life for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with systemic lupus erythematosus (SLE).
Not a fit: Patients with other autoimmune disorders that do not involve autoreactive B cells may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer treatments for patients with lupus.
How similar studies have performed: Previous research has shown promising results in understanding the role of immune cells in autoimmune diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Rahman, Ziaur — Thomas Jefferson University
- Study coordinator: Rahman, Ziaur
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.